Melagatran

Unknown Manufacturer

Technical identifiers

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Use of melagatran
US 2008058303 A1Applicant: ASTRAZENECA ABPriority: 1999
CN
US
4 publications
Dialysis method
US 2005153904 A1Applicant: ASTRAZENECA ABPriority: 1999
US
4 publications
Use of melagatran for the manufacture of a medicament for the treatment of Type 1 diabetes mellitus
US 7045502 B2Applicant: ASTRAZENECA ABPriority: 2002
US
3 publications
Combination product comprising melagatran and dexamethasone
US 7449446 B2Applicant: ASTRAZENECA ABPriority: 2001
US
2 publications
Substantially crystalline form of melagatran
US 6479078 B1Applicant: ASTRAZENECA ABPriority: 1999
US
Combination product comprising melagatran and factor VIIa inhibitor
US 2003153506 A1Applicant: BYLUND RUTHPriority: 2000
US
Combination product comprising melagatran and a factor xa inhibitor
US 2003158120 A1Applicant: ASTRZENECA ABPriority: 2000
US
Use of low molecular weight thrombin inhibitor
US 6462021 B1Applicant: ASTRAZENECA ABPriority: 2000
US
Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis
US 2004157772 A1Applicant: KIRK IANPriority: 2001
US
Combination product comprising melagatran and an anti-arrhythmic oxabispidenes
US 2006074080 A1Applicant: ASTRAZENECA ABPriority: 2002
US